Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist. - Wikidata - wikimedia - TriplyDB

Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist.

Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist.

http://www.wikidata.org/entity/Q37361444

about

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140.Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects A short term quality control tool for biodegradable microspheres.Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres.IVIVC from Long Acting Olanzapine Microspheres.Development of Risperidone PLGA Microspheres.A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres.

P2860

Q34423039-A0EDAEC9-E61E-47CC-895B-5BB52588E4F8 Q37801284-2133C5CC-AA7E-469C-9B2D-D41897A0EB5B Q40027648-A94E1181-D7EB-4205-BACC-8F83D87FB059 Q40335811-55498A17-028C-4DFD-8DBC-E958582F71EB Q41937906-455ED3F3-8259-4B1A-A668-1B9E29E95352 Q41962765-B5BDE36E-CFB2-4596-802D-B2B197EC5EFC Q41990221-7172E31A-5158-48A2-BCB2-30363F5F46F2

P2860

Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist.

http://www.wikidata.org/entity/Q37361444

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 March 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@en

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@nl

type

label

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@en

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@nl

prefLabel

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@en

Assessment of fertility in mal ...... ration with a GnRH antagonist.

@nl

P1433

Q37361444-E064E735-C985-4D34-875F-70901DAA9E57

P1476

Q37361444-ABECF849-C445-45A7-9A90-74414CCF9757

P2093

Q37361444-04844C39-2B3D-4CE2-9CE6-7A69E2E6B7C1

Q37361444-3AA4A9B7-63F9-407B-99C8-53C450D9DE10

Q37361444-6687A142-6A7D-46D7-B088-160854E1D077

Q37361444-74D61530-8426-4E16-B3B8-3754EC8BAD6E

Q37361444-E519AD3A-D4D9-4526-878E-456690849813

P2860

Q37361444-01B85CF7-8897-435C-BB3E-E40C44FB85D7

Q37361444-0CC618E2-3405-493E-AB28-B71426E043F5

Q37361444-0FC4F157-3868-4A80-A5F2-DE7EC1EFD6A2

Q37361444-143200B8-5627-41F5-877E-A1F572F61389

Q37361444-4E2DCDB5-90FD-4AB2-8011-FDB82ED1F287

Q37361444-5A5FB70A-DDB7-4474-8ECD-9D6A7C66AC54

Q37361444-7DF62FA4-A90F-49FB-BD76-037C825E23DD

Q37361444-80C23DDC-99D1-4098-AC7D-34E223D6104C

Q37361444-8F1C1115-DF93-46A2-9C5F-3183B308BCAD

Q37361444-A3FE4DD8-9129-4697-AC0E-55FCCEE7FE9D

P304

Q37361444-171127AF-7170-42D6-B608-0310F683F015

P31

Q37361444-6AE129BB-DC56-45DF-980B-430FFF46C61F

P356

Q37361444-F86C41D8-A2CC-4A33-894A-89417BA6935A

P433

Q37361444-F58A1846-ACC5-44BF-89A9-938F3CC2050F

P478

Q37361444-FA00ADA3-A7ED-4C95-A93E-AAD170556449

P50

Q37361444-6AE44B7F-7B66-428F-8FC7-83935353E678

P577

Q37361444-812C1D55-71DB-47BA-8258-6EA4008AD3D8

P5875

Q37361444-A50D4249-F0BC-4BF0-A08F-6B3B7E65FB27

P698

Q37361444-96825B68-DC62-4FB8-A886-86303EB4AB9C

P932

Q37361444-97AD370D-2B94-47F7-AFC3-A73F05E70C17

P356

P1433

P1476

Assessment of fertility in mal ...... tration with a GnRH antagonist

@en

P2093

B C Thanoo

http://www.w3.org/2001/XMLSchema#string

Patrick P DeLuca

http://www.w3.org/2001/XMLSchema#string

Santos B Murty

http://www.w3.org/2001/XMLSchema#string

Susan S D'Souza

http://www.w3.org/2001/XMLSchema#string

Wei Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

Return to fertility after extended chemical castration with a GnRH antagonist

Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres.

Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.

Meta-analysis and economic evaluation of LH-RH agonists' depot formulations in advanced prostatic carcinoma.

Development of GnRH antagonists for prostate cancer: new approaches to treatment.

Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.

Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.

Luteinizing hormone-releasing hormone antagonists in prostate cancer.

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer.

P304

E10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PS060110

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Selmin

P577

2004-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8508172

http://www.w3.org/2001/XMLSchema#string

P698

15198511

http://www.w3.org/2001/XMLSchema#string

P932

2750945

http://www.w3.org/2001/XMLSchema#string